Revelation Biosciences- Warrants(10/01/2027) Common Stock

The latest common stock for REVBW is $3.9K as of June 2026. That compares with $1.5K in the prior-year period — up 154.6% year over year. Investors often review this figure alongside Revelation Biosciences- Warrants(10/01/2027)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, REVBW's common stock moved from $1.5K to $3.9K — a 154.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Revelation Biosciences- Warrants(10/01/2027)'s operating scale or balance-sheet position.

A common stock figure of $3.9K for REVBW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting REVBW's common stock ($3.9K), review year-over-year change from $1.5K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.